0 Valutazioni
ID

40835

Descrizione

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002); ODM derived from: https://clinicaltrials.gov/show/NCT01554189

collegamento

https://clinicaltrials.gov/show/NCT01554189

Keywords

versioni (2)
  1. 21/05/20 21/05/20 -
  2. 27/09/21 27/09/21 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

21 maggio 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Eligibility Hepatitis C, Chronic NCT01554189

    Inglese

    Eligibility Hepatitis C, Chronic NCT01554189

    1 moduli  
    Inclusion Criteria
    Descrizione

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    body mass index (bmi) of 18 to ≤37 kg/m^2
    Descrizione

    Body mass index

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1305855
    diagnosis of chronic hcv infection
    Descrizione

    Hepatitis C, Chronic

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0524910
    must be infected with hcv gt1a, gt1b, or gt3
    Descrizione

    Patient Infected Hepatitis C virus genotype

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0030705
    UMLS CUI [1,2]
    C0439663
    UMLS CUI [1,3]
    C1533728
    Exclusion Criteria
    Descrizione

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    co-infection with gt1 and gt3 hcv
    Descrizione

    HCV coinfection Genotype

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C1698259
    UMLS CUI [1,2]
    C1533728
    history of stroke, chronic seizures, or major neurological disorder
    Descrizione

    Cerebrovascular accident | Seizures chronic | Nervous system disorder Major

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0038454
    UMLS CUI [2,1]
    C0036572
    UMLS CUI [2,2]
    C0205191
    UMLS CUI [3,1]
    C0027765
    UMLS CUI [3,2]
    C0205164
    history of clinically significant endocrine, gastrointestinal (excepting hcv infection), cardiovascular, hematological, immunological, renal, respiratory, or genitourinary abnormalities or diseases
    Descrizione

    Endocrine System Diseases | Gastrointestinal Diseases | Exception Hepatitis C | Cardiovascular Diseases | Hematological Disease | Immune System Diseases | Kidney Diseases | Respiration Disorders | Disorder of the genitourinary system

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0014130
    UMLS CUI [2]
    C0017178
    UMLS CUI [3,1]
    C1705847
    UMLS CUI [3,2]
    C0019196
    UMLS CUI [4]
    C0007222
    UMLS CUI [5]
    C0018939
    UMLS CUI [6]
    C0021053
    UMLS CUI [7]
    C0022658
    UMLS CUI [8]
    C0035204
    UMLS CUI [9]
    C0080276
    history of neoplastic disease
    Descrizione

    Neoplastic disease

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C1882062
    positive hepatitis b surface antigen
    Descrizione

    Hepatitis B surface antigen positive

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0149709
    history of human immunodeficiency virus (hiv) infection or positive hiv serology
    Descrizione

    HIV Infection | HIV Seropositivity

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0019693
    UMLS CUI [2]
    C0019699
    major surgery, donated or lost 1 unit of blood (approximately 500 ml) or participated in another investigational study within 4 weeks prior
    Descrizione

    Major surgery | Blood Donation Amount | Blood Loss Amount | Study Subject Participation Status | Research study

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0679637
    UMLS CUI [2,1]
    C0005794
    UMLS CUI [2,2]
    C1265611
    UMLS CUI [3,1]
    C3163616
    UMLS CUI [3,2]
    C1265611
    UMLS CUI [4]
    C2348568
    UMLS CUI [5]
    C0681814
    history of significant multiple and/or severe allergies (including latex allergy), or anaphylactic reaction or significant intolerability to prescription or non-prescription drugs or food
    Descrizione

    Multiple allergies | Severe allergy | Latex allergy | Anaphylaxis Prescription Drugs | Anaphylaxis Non-Prescription Drugs | Anaphylaxis Food | Intolerance to Prescription Drugs | Intolerance to Non-Prescription Drugs | Intolerance to Food

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0740281
    UMLS CUI [2]
    C2945656
    UMLS CUI [3]
    C0577628
    UMLS CUI [4,1]
    C0002792
    UMLS CUI [4,2]
    C0304227
    UMLS CUI [5,1]
    C0002792
    UMLS CUI [5,2]
    C0013231
    UMLS CUI [6,1]
    C0002792
    UMLS CUI [6,2]
    C0016452
    UMLS CUI [7,1]
    C1744706
    UMLS CUI [7,2]
    C0304227
    UMLS CUI [8,1]
    C1744706
    UMLS CUI [8,2]
    C0013231
    UMLS CUI [9,1]
    C1744706
    UMLS CUI [9,2]
    C0016452
    current regular user (including "recreational use") of any illicit drugs or history of drug (including alcohol) abuse within approximately 2 months
    Descrizione

    Illicit medication use | Substance Use Disorders

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0281875
    UMLS CUI [2]
    C0038586
    evidence or history of chronic hepatitis not caused by hcv including but not limited to non-hcv viral hepatitis, non-alcoholic steatohepatitis (nash), drug-induced hepatitis, autoimmune hepatitis
    Descrizione

    Hepatitis, Chronic | Etiology Absent Hepatitis C virus | Viral hepatitis | Nonalcoholic Steatohepatitis | Hepatitis, Drug-Induced | Autoimmune hepatitis

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0019189
    UMLS CUI [2,1]
    C0015127
    UMLS CUI [2,2]
    C0332197
    UMLS CUI [2,3]
    C0220847
    UMLS CUI [3]
    C0042721
    UMLS CUI [4]
    C3241937
    UMLS CUI [5]
    C1262760
    UMLS CUI [6]
    C4231138
    previous treatments(s) with nonstructural 5a (ns5a) protein inhibitors
    Descrizione

    Hepatitis C virus NS5A inhibitor

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C4041197
    treatment with protease inhibitor(s) <30 days prior to study enrollment
    Descrizione

    Protease Inhibitors

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1]
    C0033607
    previous exposure to interferon-alpha and/or ribavirin within 3 months prior to the first dose of mk-8325 in the study
    Descrizione

    Exposure to Interferon-alpha | Exposure to Ribavirin

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0332157
    UMLS CUI [1,2]
    C0002199
    UMLS CUI [2,1]
    C0332157
    UMLS CUI [2,2]
    C0035525
    clinical or laboratory evidence of advanced or decompensated liver disease; evidence of bridging fibrosis or higher grade fibrosis (metavir score ≥3) from prior liver biopsy
    Descrizione

    Liver disease Advanced | Decompensated Liver Disease | Bridging fibrosis | Fibrosis METAVIR Score

    Tipo di dati

    boolean

    Alias
    UMLS CUI [1,1]
    C0023895
    UMLS CUI [1,2]
    C0205179
    UMLS CUI [2]
    C0745744
    UMLS CUI [3]
    C0334160
    UMLS CUI [4,1]
    C0016059
    UMLS CUI [4,2]
    C3897040
    Ritorna all'inizio della pagina

    Similar models

    Eligibility Hepatitis C, Chronic NCT01554189

    1 moduli
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Body mass index
    Item
    body mass index (bmi) of 18 to ≤37 kg/m^2
    boolean
    C1305855 (UMLS CUI [1])
    Hepatitis C, Chronic
    Item
    diagnosis of chronic hcv infection
    boolean
    C0524910 (UMLS CUI [1])
    Patient Infected Hepatitis C virus genotype
    Item
    must be infected with hcv gt1a, gt1b, or gt3
    boolean
    C0030705 (UMLS CUI [1,1])
    C0439663 (UMLS CUI [1,2])
    C1533728 (UMLS CUI [1,3])
    Item Group
    C0680251 (UMLS CUI)
    HCV coinfection Genotype
    Item
    co-infection with gt1 and gt3 hcv
    boolean
    C1698259 (UMLS CUI [1,1])
    C1533728 (UMLS CUI [1,2])
    Cerebrovascular accident | Seizures chronic | Nervous system disorder Major
    Item
    history of stroke, chronic seizures, or major neurological disorder
    boolean
    C0038454 (UMLS CUI [1])
    C0036572 (UMLS CUI [2,1])
    C0205191 (UMLS CUI [2,2])
    C0027765 (UMLS CUI [3,1])
    C0205164 (UMLS CUI [3,2])
    Endocrine System Diseases | Gastrointestinal Diseases | Exception Hepatitis C | Cardiovascular Diseases | Hematological Disease | Immune System Diseases | Kidney Diseases | Respiration Disorders | Disorder of the genitourinary system
    Item
    history of clinically significant endocrine, gastrointestinal (excepting hcv infection), cardiovascular, hematological, immunological, renal, respiratory, or genitourinary abnormalities or diseases
    boolean
    C0014130 (UMLS CUI [1])
    C0017178 (UMLS CUI [2])
    C1705847 (UMLS CUI [3,1])
    C0019196 (UMLS CUI [3,2])
    C0007222 (UMLS CUI [4])
    C0018939 (UMLS CUI [5])
    C0021053 (UMLS CUI [6])
    C0022658 (UMLS CUI [7])
    C0035204 (UMLS CUI [8])
    C0080276 (UMLS CUI [9])
    Neoplastic disease
    Item
    history of neoplastic disease
    boolean
    C1882062 (UMLS CUI [1])
    Hepatitis B surface antigen positive
    Item
    positive hepatitis b surface antigen
    boolean
    C0149709 (UMLS CUI [1])
    HIV Infection | HIV Seropositivity
    Item
    history of human immunodeficiency virus (hiv) infection or positive hiv serology
    boolean
    C0019693 (UMLS CUI [1])
    C0019699 (UMLS CUI [2])
    Major surgery | Blood Donation Amount | Blood Loss Amount | Study Subject Participation Status | Research study
    Item
    major surgery, donated or lost 1 unit of blood (approximately 500 ml) or participated in another investigational study within 4 weeks prior
    boolean
    C0679637 (UMLS CUI [1])
    C0005794 (UMLS CUI [2,1])
    C1265611 (UMLS CUI [2,2])
    C3163616 (UMLS CUI [3,1])
    C1265611 (UMLS CUI [3,2])
    C2348568 (UMLS CUI [4])
    C0681814 (UMLS CUI [5])
    Multiple allergies | Severe allergy | Latex allergy | Anaphylaxis Prescription Drugs | Anaphylaxis Non-Prescription Drugs | Anaphylaxis Food | Intolerance to Prescription Drugs | Intolerance to Non-Prescription Drugs | Intolerance to Food
    Item
    history of significant multiple and/or severe allergies (including latex allergy), or anaphylactic reaction or significant intolerability to prescription or non-prescription drugs or food
    boolean
    C0740281 (UMLS CUI [1])
    C2945656 (UMLS CUI [2])
    C0577628 (UMLS CUI [3])
    C0002792 (UMLS CUI [4,1])
    C0304227 (UMLS CUI [4,2])
    C0002792 (UMLS CUI [5,1])
    C0013231 (UMLS CUI [5,2])
    C0002792 (UMLS CUI [6,1])
    C0016452 (UMLS CUI [6,2])
    C1744706 (UMLS CUI [7,1])
    C0304227 (UMLS CUI [7,2])
    C1744706 (UMLS CUI [8,1])
    C0013231 (UMLS CUI [8,2])
    C1744706 (UMLS CUI [9,1])
    C0016452 (UMLS CUI [9,2])
    Illicit medication use | Substance Use Disorders
    Item
    current regular user (including "recreational use") of any illicit drugs or history of drug (including alcohol) abuse within approximately 2 months
    boolean
    C0281875 (UMLS CUI [1])
    C0038586 (UMLS CUI [2])
    Hepatitis, Chronic | Etiology Absent Hepatitis C virus | Viral hepatitis | Nonalcoholic Steatohepatitis | Hepatitis, Drug-Induced | Autoimmune hepatitis
    Item
    evidence or history of chronic hepatitis not caused by hcv including but not limited to non-hcv viral hepatitis, non-alcoholic steatohepatitis (nash), drug-induced hepatitis, autoimmune hepatitis
    boolean
    C0019189 (UMLS CUI [1])
    C0015127 (UMLS CUI [2,1])
    C0332197 (UMLS CUI [2,2])
    C0220847 (UMLS CUI [2,3])
    C0042721 (UMLS CUI [3])
    C3241937 (UMLS CUI [4])
    C1262760 (UMLS CUI [5])
    C4231138 (UMLS CUI [6])
    Hepatitis C virus NS5A inhibitor
    Item
    previous treatments(s) with nonstructural 5a (ns5a) protein inhibitors
    boolean
    C4041197 (UMLS CUI [1])
    Protease Inhibitors
    Item
    treatment with protease inhibitor(s) <30 days prior to study enrollment
    boolean
    C0033607 (UMLS CUI [1])
    Exposure to Interferon-alpha | Exposure to Ribavirin
    Item
    previous exposure to interferon-alpha and/or ribavirin within 3 months prior to the first dose of mk-8325 in the study
    boolean
    C0332157 (UMLS CUI [1,1])
    C0002199 (UMLS CUI [1,2])
    C0332157 (UMLS CUI [2,1])
    C0035525 (UMLS CUI [2,2])
    Liver disease Advanced | Decompensated Liver Disease | Bridging fibrosis | Fibrosis METAVIR Score
    Item
    clinical or laboratory evidence of advanced or decompensated liver disease; evidence of bridging fibrosis or higher grade fibrosis (metavir score ≥3) from prior liver biopsy
    boolean
    C0023895 (UMLS CUI [1,1])
    C0205179 (UMLS CUI [1,2])
    C0745744 (UMLS CUI [2])
    C0334160 (UMLS CUI [3])
    C0016059 (UMLS CUI [4,1])
    C3897040 (UMLS CUI [4,2])
    Ritorna all'inizio della pagina 

    Aiuto

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial